Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratory

Abstract

Studies monitoring immunoglobulin (Ig) antigen specificity have brought to light key Ig biomarkers for immunity, autoimmunity, cancer detection, and immune system function evaluation. A fundamentally new approach to the detection of Igs based on the primary structure of the Ig is beginning to emerge in the literature. This approach has only become feasible in light of advances in proteomics and rapid improvements in mass spectrometry (MS). Driven primarily by the development of Ig pharmaceuticals, Ig MS-based proteomic methods are revealing structural features which were previously unavailable with other characterization techniques. The task of adapting these techniques to clinical chemistry is in its infancy, but these methods have the potential to dramatically alter testing for Ig biomarkers. The purpose of this article is to review the advances that have been made in proteomic characterization of Igs by MS and the early attempts to apply these methods to clinical samples.

• Antibody
• autoimmunity
• biomarkers
• immunoglobulin
• mass spectrometry
• monoclonal therapeutics
• proteomics

Notes

*Referee: Dr. Roman Zubarev, Professor of Medical Proteomics at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet.